Abstract:Background: Non-small cell lung cancer (NSCLC) accounts for 85 % of all lung cancers, the leading cause of cancer-related deaths worldwide. Despite recent advancements in NSCLC treatment, such as targeted therapy and immunotherapy, a large proportion of NSCLC patients develop drug resistance. Thus, development of new effective treatments for NSCLC is urgently needed. Traditional Chinese medicine may provide sources for developing new anti-cancer drugs. Although Scutellaria baicalensis (SB) has been proven to have anti-cancer effects, its action mechanism on NSCLC is not yet fully understood. Here we used network pharmacology to investigate the potential mechanism of SB treating NSCLC. Methods: We identified the active constituents of SB from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and predicted their potential targets using the SwissTargetPrediction database. Next, therapeutic targets for NSCLC were screened using five databases: GeneCards, DisGeNET, DrugBank, Online Mendelian Inheritance in Man (OMIM), and Therapeutic Target Database (TTD). A protein-protein interaction (PPI) network of the common targets between SB and NSCLC was constructed using STRING were visualized using Cytoscape. We also performed enrichment analysis of these targets to identify gene ontology (GO) and KEGG pathways associated with them. Finally, we conducted molecular docking analysis using Autodock Vina and PyMOL to investigate the interactions between active SB components and NSCLC targets. Furthermore, we performed in vitro experimental validations of the findings by bioinformatics analysis. Results: We identified 35 active compounds of SB and their 463 potential targets, and 1,073 NSCLC-associated targets. A total of 140 targets overlapped between the SB and NSCLC targets. PPI network analysis and drug-ingredient-target network analysis identified SRC, HSP90AA1, STAT3, AKT1, and MAPK3 as the core target proteins, and baicalein, 5,7,2,5-tetrahydroxy-8,6-dimethoxyflavone, skullcapflavone II, tenaxin I, and rivularin as critical active compounds of SB. GO and pathway enrichment analysis uncovered pathways significantly associated with the common targets between SB and NSCLC, including PI3K-Akt signaling, VEGF, and EGFR tyrosine kinase inhibitor resistance. Molecular docking revealed a stable binding between the main active components and core targets. In vitro experiments showed that baicalein suppressed A549 cell proliferation in a concentration-dependent manner, induced apoptosis, and caused cell cycle arrest in the S phase. Moreover, baicalein inhibited A549 cell migration and activation of the PI3K/Akt pathway. Conclusions: SB has a potential to treat NSCLC through multiple targets and pathways. This study afforded potential targets for further experimental research to explore the mechanism of SB in the treatment of NSCLC.

Mechanism of the Effect of Scopolamine on Breast Cancer: Determination by Network Pharmacology and Bioinformatics

The Mechanism of Scopolamine's Effect on Migration Function of Lung Cancer Cells: A Network Pharmacology and Bioinformatics Perspective

Mechanisms Involved in Therapeutic Effects of Scutellaria baicalensis Georgi in Oral Squamous Cell Carcinoma Based on Systems Biology and Structural Bioinformatics Approaches

Scopolin obtained from Smilax china L. against hepatocellular carcinoma by inhibiting glycolysis: A network pharmacology and experimental study

Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification

Investigating the Mechanism of Scutellariae barbata Herba in the Treatment of Colorectal Cancer by Network Pharmacology and Molecular Docking

Exploring the Mechanism of Shen Qi Gui Oral Liquid against Chemotherapy-Induced Myelosuppression in Cancer Patients Based on Network Pharmacology and Molecular Docking

The Use of Network Pharmacology to Investigate the Mechanism of Action of Scutellaria Barbata in the Treatment of Prostate Cancer

Revealing the molecular mechanism of baohuoside I for the treatment of breast cancer based on network pharmacology and molecular docking

Exploring Targets and Related Mechanisms of Scutellaria Baicalensis for Treating Non-Small Cell Lung Cancer Based on Network Pharmacology

Mechanisms Underlying the Therapeutic Effects of Banzhilian- Baihuasheshecao for Treating Pancreatic Ductal Adenocarcinoma Based on Bioinformatics Strategy

Molecular mechanism of Spatholobi Caulis treatment for cholangiocarcinoma based on network pharmacology, molecular docking, and molecular dynamics simulation

Network Pharmacology-Based Approach to Investigate the Mechanisms of Shenqi Fuzheng Injection in the Treatment of Breast Cancer

Mechanistic Role of Scutellaria Baicalensis Georgi in Breast Cancer Therapy.

Pharmacodynamic Materials and Mechanisms of Compound Scutellariae Radix Granules for Colorectal Cancer: A Network Pharmacology, Molecular Docking and Cell Experiments Study

Study on the Mechanism of Competing Endogenous Network of 'Scutellaria barbata D.Don-Houttuynia cordata- Radix Scutellariae' in the Treatment of NSCLC based on Bioinformatics, Molecular Dynamics and Experimental Verification

Study on the mechanism of action of Scutellaria barbata on hepatocellular carcinoma based on network pharmacology and bioinformatics

Molecular docking and network pharmacological analysis of Scutellaria baicalensis against renal cell carcinoma

Study on the Molecular Mechanism of the Herbal Couple Sparganii Rhizoma-Curcumae Rhizoma in the Treatment of Lung Cancer Based on Network Pharmacology

Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology with Targetable Screening from the Cancer Genome Atlas

To explore the effect of kaempferol on non-small cell lung cancer based on network pharmacology and molecular docking